Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
John K. Chan(Cancer Research Institute), Bradley J. Monk(Creighton University)
Cited by 365
Related Papers
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
|British Journal of Cancer|2006|658